Introducing our latest publication on SARS-CoV-2 RNA reference material. A significant contribution for all medical laboratories to standardize SARS-CoV-2 RNA diagnostics.
On December 16, 2021, the European Parliament adopted a differentiated deferral of the application of individual components of the IVDR. This also partly affects in-vitro-diagnostics from in-house production.
The quantitative reference samples for virus genome detection of SARS-CoV-2 can be ordered again to be shipped on the 26th January, 2022 (group 7340).
INSTAND EQA Scheme 416 - Virus Immunology Anti-SARS-CoV-2 - March 2022 extended by 2 additional control samples for an international study by EQALM
We are pleased to present our new 2022 EQA scheme program.
You can register now for the following 2021 EQA schemes.
The registration deadline is between September 3 and 24, 2021, depending on the EQA scheme.
Prof. Dr. rer. nat. Ingo Schellenberg, Vice President of the Board at INSTAND, introduces INSTAND at Medlab 2021.
The overall overviews and associated reports for all EQA schemes can now be accessed in RV-Online.
With the redesign of the INSTAND website, we took the opportunity to restructure the EQA service area. Learn more here!
In July 2021, INSTAND launches a new EQA scheme for the determination of Glucose-6 phosphate-dehydrogenase (279). This EQA scheme will be offered twice a year from now on.
Page 1 of 2.